Search results
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
Atlanta Journal-Constitution· 5 days agoNEW YORK (AP) — Reports of a rare nervous system disorder were "more common than expected" in older...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 1 day agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 4 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 1 day agoThe RSV vaccine, known as mResvia, was approved to protect adults 60 years and older from lower...
S2 Episode 6: When RSV Hits Home: Community Care in Rural West Virginia
Medscape· 10 hours agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says
MedPage Today· 4 days ago...revealed that there were 1.5 reports of GBS per 1 million doses administered of the GSK RSV vaccine (Arexvy), and 5 reports per 1 million doses administered of the Pfizer RSV vaccine (Abrysvo), according to researchers led by Anne Hause, PhD, of the CDC's National Center for Emerging and Zoonotic...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
